Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEvraz Regulatory News (EVR)

  • This share is currently suspended. It was suspended at a price of 82.52

Share Price Information for Evraz (EVR)

Share Price is delayed by 15 minutes
Get Live Data
82.52    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £1.20b
EVR Live PriceLast checked at - London Stock Exchange

Intraday Evraz Share Chart

Stabilisation Notice

26 Mar 2019 09:37

RNS Number : 0237U
J.P. Morgan Securities PLC.
26 March 2019
 

26 March 2019

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Evraz PLC

Pre-stabilisation Period Announcement

J.P. Morgan Securities plc, (contact: Emma Lovett 0207 134 2468) hereby gives notice, as Stabilisation Coordinator, that the Stabilising Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation EU/xxx/2016 under the Market Abuse Regulation (EU/596/2016).

The securities:

Issuer:

Evraz PLC

Guarantor (if any):

 

Aggregate nominal amount:

USD TBD

Description:

USD 5yr

Senior, Unsecured, 144A / Reg S

Offer price:

Other offer terms:

USD 200,000 x 1,000

Stabilisation:

Stabilisation Manager(s):

J.P. Morgan Securities plc (Stabilisation coordinator)

Gazprom Bank (Stabilisation Manager(s))

ING (Stabilisation Manager(s))

BAML (Stabilisation Manager(s))

Sberbank (Stabilisation Manager(s))

Renaissance Capital (Stabilisation Manager(s))

 

Stabilisation period expected to start on:

26 March 2019

Stabilisation period expected to end no later than:

26 April 2019

Existence, maximum size and conditions of use of overallotment facility:

The Stabilisation Manager(s) may over-allot the securities in an amount not exceeding 5% of the aggregate nominal amount stated above.

Stabilisation trading venue:

Over the counter, TBC

 

In connection with the offer of the above securities, the Stabilising Manager(s), or persons acting on behalf of the Stabilising Manager(s) may over-allot the securities, provided that the aggregate principal amount of the securities allotted does not exceed 105 percent of the aggregate principal amount of the securities, or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time, but it must end no later than the earlier of 30 days after the issue date of the securities and 60 days after the date of allotment of the securities.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that in that Member State

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STAEANDKADFNEEF
Date   Source Headline
29th Apr 20201:16 pmRNSTransfer of shares out of treasury, Voting rights
27th Apr 20206:39 pmRNSEVRAZ PUBLISHES ITS SUSTAINABILITY REPORT FOR 2019
27th Apr 202010:47 amRNSPublication of share rights summary at NSM
24th Apr 20203:00 pmRNSNOTICE OF Q1 2020 TRADING UPDATE CONFERENCE CALL
16th Apr 20202:00 pmRNSUpdate on COVID-19
20th Mar 202011:00 amRNSEVRAZ signed US$750m syndicated credit facility
10th Mar 20206:00 pmRNSDividend - determination of currency amounts
27th Feb 20207:00 amRNSAnnual Financial Report
21st Feb 202010:34 amRNSNOTICE OF 2019 RESULTS AND CONFERENCE CALL DETAILS
30th Jan 20209:03 amRNSEVRAZ Q4 2019 TRADING UPDATE - CORRECTION
30th Jan 20207:00 amRNSEVRAZ Q4 2019 TRADING UPDATE
31st Dec 201910:00 amRNSAmendment of transshipment agreement
13th Dec 20191:00 pmRNSChange of Director's responsibilities
2nd Dec 20196:00 pmRNSChange of director's details
1st Nov 20197:00 amRNSEVRAZ Q3 2019 TRADING UPDATE
31st Oct 20193:15 pmRNSDisclosure on Tailings Storage Facilities
28th Oct 20199:54 amRNSNOTICE OF Q3 2019 TRADING UPDATE CONFERENCE CALL
18th Oct 20196:00 pmRNSACQUISITION - PILOT PLANT FOR TAILINGS PROCESSING
18th Oct 20197:00 amRNSEVRAZ holds Capital markets day
9th Sep 20193:00 pmRNSDirector/PDMR Shareholding
21st Aug 20194:00 pmRNSDividend - determination of currency amounts
16th Aug 20194:00 pmRNSAmendment of transshipment agreement
8th Aug 20197:00 amRNSHalf-year Report
2nd Aug 20198:19 amRNSNOTICE OF H1 2019 RESULTS, CONFERENCE CALL DETAILS
1st Aug 20196:01 pmRNSChange of registered office address
31st Jul 20191:17 pmRNSEVRAZ Q2 2019 TRADING UPDATE - CORRECTION
31st Jul 20197:00 amRNSEVRAZ Q2 2019 TRADING UPDATE
25th Jul 20194:31 pmRNSEVRAZ Priced 20 Billion Rouble Bond Issue
25th Jun 20198:42 amRNSModern Slavery Transparency Statement for 2018
20th Jun 20196:00 pmRNSHolding(s) in Company
20th Jun 20197:02 amRNSDirector/PDMR Shareholding
20th Jun 20197:00 amRNSCompletion of sale of existing shares of EVRAZ
19th Jun 20194:58 pmRNSIntended sale of existing ordinary shares of EVRAZ
18th Jun 20191:33 pmRNSResult of AGM
18th Jun 20198:40 amRNSReport on payments to governments for 2018
6th Jun 201910:00 amRNSChange of director's details
23rd May 20193:37 pmRNSEarly Redemption Notice of 6.50 Notes due 2020
14th May 20196:27 pmRNSDirector/PDMR Shareholding
3rd May 20196:02 pmRNSHolding(s) in Company
3rd May 20196:00 pmRNSHolding(s) in Company
3rd May 20195:05 pmRNSNotice of 2019 AGM
30th Apr 20193:54 pmRNSTransfer of shares out of treasury, Voting rights
29th Apr 201910:24 amRNSEVRAZ PUBLISHES ITS FIRST SUSTAINABILITY REPORT
29th Apr 20197:00 amRNSEVRAZ Q1 2019 TRADING UPDATE
26th Apr 20191:31 pmRNSEarly Redemption Notice
25th Apr 20196:29 pmRNSACQUISITION OF 100% IN LLC ZAPADNYE VOROTA
25th Apr 20199:00 amRNSChange of director's details
11th Apr 20198:37 amRNSNOTICE OF Q1 2019 TRADING UPDATE CONFERENCE CALL
2nd Apr 201912:36 pmRNSDirector/PDMR Shareholding
29th Mar 20191:24 pmRNSDirector/PDMR Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.